1. Baik, K., Yoo, E., Byun, Y., Lee, S., Jang, B., Son, H., Lee, J., Cho, J., Lee, S., Moon, S., Park, J., and Lee, B. Novel 3,4-dialkoxyphenylderivativesand their therapeutic use thereof. Patent: W09842666,1998.
2. Cho, J. Y., Park, J., Yoo, E. S., Yoshikawa, K., Baik, K. U., Lee, J. S. and Park, M. H. Inhibitory effect of lignans from the rhizomes of Coptis japonica var. dissecta on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells.Arch. Pharm. Res., 21, 12–16 (1998).
3. Cho, J. Y., Park, J., Son, H. J., Park, J. S., Yoo, E. S., Baik, K. U., and Park, M. H. Effects of dialkoxylphenyl compoundswith oxime group on activated macrophages and lymphocytes. Submitted (2001).
4. Eigler A., Sinha B., Hartmann G., Endres S., Taming TNF: strategies to restrain this proinflammatory cytokine.Immunology Today, 18, 487–492 (1997).
5. Espat, N. J., Copeland, E. M. and Moldawer, L. L. Tumor necrosis factor and cachexia: a current perspective.Surg. Oncol., 3, 255–262 (1994).